A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
A new prophylactic posaconazole dosing regimen of 120mg/m² tid is evaluated pharmacologically
in children 13 years and younger, suffering from a hematologic malignancy.
Phase:
Phase 4
Details
Lead Sponsor:
Universitaire Ziekenhuizen Leuven
Collaborators:
Institutul Clinic Fundeni Institutul Clinic Fundeni Bucharest